UBS Group’s Molecular Partners MOLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39K | Buy |
10,199
+3,848
| +61% | +$14.7K | ﹤0.01% | 6679 |
|
|
2025
Q1 | $24.6K | Sell |
6,351
-521
| -8% | -$2.02K | ﹤0.01% | 6789 |
|
|
2024
Q4 | $32.6K | Buy |
6,872
+1,626
| +31% | +$7.72K | ﹤0.01% | 6323 |
|
|
2024
Q3 | $26.7K | Buy |
5,246
+1,785
| +52% | +$9.08K | ﹤0.01% | 5979 |
|
|
2024
Q2 | $25K | Buy |
3,461
+3,135
| +962% | +$22.7K | ﹤0.01% | 6005 |
|
|
2024
Q1 | $1.27K | Buy |
+326
| New | +$1.27K | ﹤0.01% | 6999 |
|
|
2023
Q1 | – | Sell |
-2,958
| Closed | -$19.4K | – | 8804 |
|
|
2022
Q4 | $19.4K | Buy |
+2,958
| New | +$19.4K | ﹤0.01% | 6500 |
|
|
2022
Q2 | – | Sell |
-611
| Closed | -$12K | – | 9532 |
|
|
2022
Q1 | $12K | Sell |
611
-2,796
| -82% | -$54.9K | ﹤0.01% | 7141 |
|
|
2021
Q4 | $65K | Buy |
+3,407
| New | +$65K | ﹤0.01% | 5596 |
|
|
2021
Q3 | – | Sell |
-23
| Closed | – | – | 8611 |
|
|
2021
Q2 | $0 | Buy |
+23
| New | – | ﹤0.01% | 8450 |
|